# EDGAR Filing Document

**Accession Number:** 0001835268
**File Stem:** 0001193125-25-145761
**Filing Date:** 2025-6
**Character Count:** 2333
**Document Hash:** ce184ad28c263859ab8186ddf6eb8839
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-145761.hdr.sgml**: 20250725

**ACCESSION NUMBER**: 0001193125-25-145761

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250624

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Connect Biopharma Holdings Ltd
- **CENTRAL INDEX KEY:** 0001835268
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 3580 CARMEL MOUNTAIN ROAD, SUITE 200
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92130
- **BUSINESS PHONE:** 858-727-1040

**MAIL ADDRESS:**
- **STREET 1:** 3580 CARMEL MOUNTAIN ROAD, SUITE 200
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92130

**Connect Biopharma Holdings Limited** 

**3580 Carmel Mountain Road, Suite 200** 

**San Diego, CA 92130** 

June 24, 2025

**<u>VIA EDGAR</u>**

Alan Campbell

Office of Life Sciences

Division of Corporation Finance

U.S. Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

---

| | |
|:---|:---|
| **Re:** | **Connect Biopharma Holdings Limited**  |

---

**Registration Statement on Form F-3** 

**File No. 333-287918** 

To the addressee set forth above:

Pursuant to Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, on behalf of Connect Biopharma Holdings Limited, respectfully requests that the effective date of the Registration Statement on Form F-3 referred to above be accelerated so that it will become effective at 4:00 P.M. Eastern Time on June 26, 2025, or as soon as practicable thereafter.

If you have any questions or require additional information, please contact Michael E. Sullivan of Latham & Watkins LLP at (858) 523-3959. Thank you for your assistance and cooperation in this matter.

---

| | |
|:---|:---|
|  Sincerely, | Sincerely, |
|  CONNECT BIOPHARMA HOLDINGS LIMITED | CONNECT BIOPHARMA HOLDINGS LIMITED |
|  By: | /s/ Jeff Cohn |
|  | Jeff Cohn |
|  | General Counsel and Corporate Secretary |

---

cc: Barry Quart, Pharm.D., *Connect Biopharma Holdings Limited*

Michael E. Sullivan, *Latham & Watkins LLP*